Dotmatics’ Post

Accelerate Drug Discovery with AI Power! Unlock the potential of precision medicine with IDM Insight. Armed with our ground-breaking AI-powered Target Database, integrating over 6,000 human targets, we offer unparalleled insights to fast-track your drug discovery journey. From rapid target validation to seamless integration with disease and compound data, our platform is designed to revolutionize how we approach therapeutic development. Leverage cutting-edge AI for in-depth analysis and predictive modeling, ensuring your research stays ahead of the curve in the quest for novel treatments. Click to explore how our AI-enhanced platform can transform your research today. #IDMInsight #AI #DrugDiscovery #Innovation #PharmaTech #MarketAccess

AI-native multimodal science is today's reality in drug discovery. Dotmatics is a believer in the 'lab in loop' framework that will break down data silos and harness the true potential of AI to drive massive efficiency into the R&D process. Thanks Philip Mounteney for the insightful perspective.

As global concerns for environmental sustainability grow, more biotech firms are adopting AI to promote eco-friendly practices. AI transforms traditional drug development, speeding up candidate identification, predicting efficacy, and refining chemical structures from vast datasets. At QuantHealth, we are taking this approach to reduce physical experiments, cut energy use, minimize waste in trials, and optimize manufacturing by streamlining processes with machine learning. To learn more about how QuantHealth is engineering clinical trials with AI visit https://quanthealth.ai/

We've developed a closed loop discovery system that merges molecular design prowess with biological assay data. This allows us to iteratively construct high precision predictive models, enhancing the efficiency and accuracy of drug discovery. Learn more about how our integrated system is advancing small molecule drug development on our website. https://okt.to/2H1YT5 #Logica #AI #drugdiscovery #LogicaAI

What does the future of healthcare look like? I love the UNITY in thought across the DIVERSITY of experts (John Apathy, Anubhav Srivastava, Ranjit Kumble, Funda Gunes, Ph.D., Sahab Aslam, Rory Kelleher, David West, Kyle Tretina, PhD, Christopher Mason, Daniel Kinney, Jonathan Crowther, Harini Gopalakrishnan shown in this trailer to name just a few) on how AI and emerging technologies will impact this industry in the coming years in our final episode of #AI&US from Dataiku

𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹: 𝗛𝗼𝘄 𝗔𝗜 𝗶𝘀 𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗽𝗶𝗽𝗲𝗹𝗶𝗻𝗲 AI is streamlining drug development, speeding up the process while reducing costs. 🚀 Tune in to a recent webinar from Sano Genetics, hosted by our very own COO, Charlotte Guzzo to explore this fascinating space with leading industry experts (Parker Moss, Margo Georgiadis and Guillermo Del Angel). Check it out here: 👇 https://lnkd.in/dcVkXtHt #ClinicalTrials #PrecisionMedicine

How will #AI transform the #lifesciences sector? Join our webinar to hear Claus Andersen and others from across the Baker Tilly network discuss how to harness AI for innovation and growth.

Unleash the future of pharma innovation on our 25th European Pharma and Biotech PPM Conference with Intelligencia AI! Since 2017, they've been revolutionizing drug development with cutting-edge data science and AI. Meet with intelligencia.ai in person and with us in London!  #PharmaInnovation #IntelligenciaAI #DataScienceRevolution 🎊

We make billion- and trillion-scale molecular spaces accessible for search and filtering by properties. Our CTO Miroslav Lžičař gave a talk on how we do it in the Miton AI times series of talks. You can watch the full recording and the following discussion here: https://lnkd.in/dZHXUYdr #artificialintelligence #drugdiscovery #medicinalchemistry #drugdevelopment #machinelearning #propertyprediction #cheese #deepmedchem

Been thinking about planning a trip to London? Do you work in the #pharmaceutical space? If so, we hope to see you at the upcoming Why Summits event where we'll be sharing more on how #AI can take your #drugportfolio strategy to the next level. If you aren't traveling to London, then reach out to Marianna Esposito, PhD or Edoardo Madussi to connect more and learn about our approach to AI-driven #PTRS.